Abstract | OBJECTIVE: To assess the potential benefit of intralesional administration of cidofovir, an acyclic nucleoside phosphonate with activity against several DNA viruses, for treating severe respiratory papillomas in pediatric patients. DESIGN: Prospective case series. SETTING: Tertiary care children's hospitals. PATIENTS: INTERVENTION: MAIN OUTCOME MEASURE:
Papilloma stage at time of serial laryngoscopies. RESULTS: One patient was disease free and 3 patients demonstrated a dramatic response to adjuvant therapy with cidofovir at the 9-month follow-up visit after the last injection of cidofovir. One patient showed an improvement in papilloma stage that was possibly related to concurrent therapy with interferon. CONCLUSIONS:
|
Authors | S M Pransky, A E Magit, D B Kearns, D R Kang, N O Duncan |
Journal | Archives of otolaryngology--head & neck surgery
(Arch Otolaryngol Head Neck Surg)
Vol. 125
Issue 10
Pg. 1143-8
(Oct 1999)
ISSN: 0886-4470 [Print] United States |
PMID | 10522508
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Organophosphonates
- Organophosphorus Compounds
- Cytosine
- Cidofovir
|
Topics |
- Antiviral Agents
(administration & dosage, therapeutic use)
- Child, Preschool
- Cidofovir
- Cytosine
(administration & dosage, analogs & derivatives, therapeutic use)
- Female
- Humans
- Infant
- Injections, Intralesional
- Laryngeal Neoplasms
(drug therapy)
- Male
- Organophosphonates
- Organophosphorus Compounds
(administration & dosage, therapeutic use)
- Papilloma
(drug therapy)
- Pilot Projects
- Prospective Studies
- Recurrence
- Treatment Outcome
|